Posts
Hospitology and Healthcare Huddle – 05/01/2022
BUSINESS Strike. Around 5K Stanford nurses went on strike last week. The ask? Better pay and better staffing. The strike highlights a trend of unionized nurses fighting for better working conditions. The Deets Unionized Stanford nurses have three asks: Provide real solutions for staffing. Offer competitive wages and benefits. Work to address the exodus of nurses from the injury. Stanford nurses and…
Read MoreThe Next Bitcoin?
DEEP DIVE The Next Bitcoin? Will today’s cannabis stockholders be tomorrow’s millionaires? Imagine holding stock in a company you knew, without a shadow of a doubt, was on the one-way train to success. Well, as much as we can be sure about the stock market, anyway. If the last few years have taught us anything,…
Read MoreMedicare Disadvantage?
INSURANCE Medicare Disadvantage? Some Medicare Advantage health plans have wrongfully denied or delayed prior authorizations and payment requests, according to a new report from the Office of the Inspector General. Are these MA plans genuinely “great” if they only burden patients and providers? Some BackgroundThe $412 billion MA market is booming. MA plans saw an 8.8% increase in enrollment…
Read MoreSharma- 05/01/2022
Happy Sunday! I hope if you’re reading this, you had a successfully relaxing weekend, got a good amount of rest, ate some good food, and you’re ready to get chatty about driving sell-through in retail. Before we jump into that, please do take 23 seconds to copy the link below, open iMessage, find a marketing…
Read MoreThe Next Frontier of Weight Loss
Eli Lilly’s diabetes drug, tirzepatide, led to a max 22.5% weight loss—or 52 pounds—in adults with obesity or overweight. Some have described tirzepatide’s effects as the “equivalent of inventing nuclear fusion.” Bold statement. But I agree nonetheless that these clinical trial results are a BFD for public health. The Deets Tirzepatide is a GLP-1 receptor agonist mixed with a…
Read MoreThe man who lost $20B in 2 days.
The rise and fall of Bill Hwang This Bloomberg Businessweek headline from April 2021 is an all-timer: “Bill Hwang Had $20 Billion, Then Lost It All in Two Days.” The implosion of Hwang’s hedge fund Archegos Capital shook Wall Street. Veteran traders called it the largest sum of money that had ever been lost in such a…
Read More